Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Magnification endoscopy with optical chromoendoscopy shows strong correlation with histologic inflammation in patients with inflammatory bowel disease.

Klenske E, Atreya R, Hartmann A, Fischer S, Hirschmann S, Zundler S, Iaccuci M, Neurath MF, Rath T.

Endosc Int Open. 2019 Aug;7(8):E1018-E1026. doi: 10.1055/a-0953-1334. Epub 2019 Aug 8.

2.

A comparative analysis of articular bone in large cohort of patients with chronic inflammatory diseases of the joints, the gut and the skin.

Simon D, Kleyer A, Englbrecht M, Stemmler F, Simon C, Berlin A, Kocijan R, Haschka J, Hirschmann S, Atreya R, Neurath MF, Sticherling M, Rech J, Hueber AJ, Engelke K, Schett G.

Bone. 2018 Nov;116:87-93. doi: 10.1016/j.bone.2018.07.017. Epub 2018 Jul 23.

PMID:
30048820
3.

Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's disease.

Schmitt H, Billmeier U, Dieterich W, Rath T, Sonnewald S, Reid S, Hirschmann S, Hildner K, Waldner MJ, Mudter J, Hartmann A, Grützmann R, Neufert C, Münster T, Neurath MF, Atreya R.

Gut. 2019 May;68(5):814-828. doi: 10.1136/gutjnl-2017-315671. Epub 2018 May 30.

4.

Pneumococcal Metabolic Adaptation and Colonization Are Regulated by the Two-Component Regulatory System 08.

Gómez-Mejia A, Gámez G, Hirschmann S, Kluger V, Rath H, Böhm S, Voss F, Kakar N, Petruschka L, Völker U, Brückner R, Mäder U, Hammerschmidt S.

mSphere. 2018 May 16;3(3). pii: e00165-18. doi: 10.1128/mSphere.00165-18. eCollection 2018 May-Jun.

5.

The Impact of 'Being There': Psychiatric Staff Attitudes on the Use of Restraint.

Dahan S, Levi G, Behrbalk P, Bronstein I, Hirschmann S, Lev-Ran S.

Psychiatr Q. 2018 Mar;89(1):191-199. doi: 10.1007/s11126-017-9524-9.

PMID:
28721655
6.

Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression Profiles.

Fuchs F, Schillinger D, Atreya R, Hirschmann S, Fischer S, Neufert C, Atreya I, Neurath MF, Zundler S.

Front Immunol. 2017 Jul 3;8:764. doi: 10.3389/fimmu.2017.00764. eCollection 2017.

7.

Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis.

Voskens CJ, Fischer A, Roessner S, Lorenz C, Hirschmann S, Atreya R, Neufert C, Atreya I, Neurath MF, Schuler G.

Inflamm Bowel Dis. 2017 Aug;23(8):1348-1359. doi: 10.1097/MIB.0000000000001192.

PMID:
28708802
8.

Safety and efficacy of intravenous cyclophosphamide pulse therapy in therapy refractory Crohn's disease patients.

Hirschmann S, Atreya R, Englbrecht M, Neurath MF.

J Physiol Pharmacol. 2017 Feb;68(1):57-67.

9.

Top-down approach to biological therapy of Crohn's disease.

Hirschmann S, Neurath MF.

Expert Opin Biol Ther. 2017 Mar;17(3):285-293. doi: 10.1080/14712598.2017.1287170. Epub 2017 Feb 6. Review.

PMID:
28132526
10.

Enhancing the Safety Climate and Reducing Violence Against Staff in Closed Hospital Wards.

Isaak V, Vashdi D, Bar-Noy D, Kostisky H, Hirschmann S, Grinshpoon A.

Workplace Health Saf. 2017 Sep;65(9):409-416. doi: 10.1177/2165079916672478. Epub 2016 Dec 9.

PMID:
27941087
11.

High-resolution Quantitative Computed Tomography Demonstrates Structural Defects in Cortical and Trabecular Bone in IBD Patients.

Haschka J, Hirschmann S, Kleyer A, Englbrecht M, Faustini F, Simon D, Figueiredo CP, Schuster L, Muschitz C, Kocijan R, Resch H, Atreya R, Rech J, Neurath MF, Schett G.

J Crohns Colitis. 2016 May;10(5):532-40. doi: 10.1093/ecco-jcc/jjw012. Epub 2016 Jan 27.

13.

The Rubber Hand Illusion paradigm as a sensory learning process in patients with schizophrenia.

Lev-Ari L, Hirschmann S, Dyskin O, Goldman O, Hirschmann I.

Eur Psychiatry. 2015 Oct;30(7):868-73. doi: 10.1016/j.eurpsy.2015.06.008. Epub 2015 Sep 25.

PMID:
26443055
14.

Functional Brain Imaging Reveals Rapid Blockade of Abdominal Pain Response Upon Anti-TNF Therapy in Crohn's Disease.

Hess A, Roesch J, Saake M, Sergeeva M, Hirschmann S, Neumann H, Dörfler A, Neurath MF, Atreya R.

Gastroenterology. 2015 Oct;149(4):864-6. doi: 10.1053/j.gastro.2015.05.063. Epub 2015 Aug 8. No abstract available.

PMID:
26264347
15.

Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo.

Fischer A, Zundler S, Atreya R, Rath T, Voskens C, Hirschmann S, López-Posadas R, Watson A, Becker C, Schuler G, Neufert C, Atreya I, Neurath MF.

Gut. 2016 Oct;65(10):1642-64. doi: 10.1136/gutjnl-2015-310022. Epub 2015 Jul 24.

16.

Cyclosporine A regulates pro-inflammatory cytokine production in ulcerative colitis.

Steiner S, Daniel C, Fischer A, Atreya I, Hirschmann S, Waldner M, Neumann H, Neurath M, Atreya R, Weigmann B.

Arch Immunol Ther Exp (Warsz). 2015 Feb;63(1):53-63. doi: 10.1007/s00005-014-0309-7. Epub 2014 Aug 26.

PMID:
25155925
17.

Modern diagnosis of celiac disease and relevant differential diagnoses in the case of cereal intolerance.

Hahn M, Hagel AF, Hirschmann S, Bechthold C, Konturek P, Neurath M, Raithel M.

Allergo J Int. 2014;23(2):67-77. Epub 2014 Mar 19. Review.

18.

Late-onset psychosis and risedronate treatment for osteoporosis.

Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A.

Clin Schizophr Relat Psychoses. 2015 Apr;9(1):36-9. doi: 10.3371/CSRP.HIGI.043013.

PMID:
23644167
19.

Management of the suicidal patient in the era of defensive medicine: focus on suicide risk assessment and boundaries of responsibility.

Bleich A, Baruch Y, Hirschmann S, Lubin G, Melamed Y, Zemishlany Z, Kaplan Z.

Isr Med Assoc J. 2011 Nov;13(11):653-6. Review.

20.

FT-IR-cPAS--new photoacoustic measurement technique for analysis of hot gases: a case study on VOCs.

Hirschmann CB, Koivikko NS, Raittila J, Tenhunen J, Ojala S, Rahkamaa-Tolonen K, Marbach R, Hirschmann S, Keiski RL.

Sensors (Basel). 2011;11(5):5270-89. doi: 10.3390/s110505270. Epub 2011 May 16.

21.

The psychological costs and benefits of being highly persistent: personality profiles distinguish mood disorders from anxiety disorders.

Cloninger CR, Zohar AH, Hirschmann S, Dahan D.

J Affect Disord. 2012 Feb;136(3):758-66. doi: 10.1016/j.jad.2011.09.046. Epub 2011 Oct 28.

PMID:
22036800
22.

Control: patients' aggression in psychiatric settings.

Drach-Zahavy A, Goldblatt H, Granot M, Hirschmann S, Kostintski H.

Qual Health Res. 2012 Jan;22(1):43-53. doi: 10.1177/1049732311414730. Epub 2011 Jul 8.

PMID:
21743032
23.

Predictors of quality of life in major psychoses: a naturalistic follow-up study.

Ritsner M, Kurs R, Gibel A, Hirschmann S, Shinkarenko E, Ratner Y.

J Clin Psychiatry. 2003 Mar;64(3):308-15.

PMID:
12716273
24.

Clinical evaluation of prior suicide attempts and suicide risk in psychiatric inpatients.

Modai I, Hirschmann S, Hadjez J, Bernat C, Gelber D, Ratner Y, Rivkin O, Kurs R, Ponizovsky A, Ritsner M.

Crisis. 2002;23(2):47-54.

PMID:
12500888
25.

Combined clozapine and valproic acid treatment-induced agranulocytosis.

Madeb R, Hirschmann S, Kurs R, Turkie A, Modai I.

Eur Psychiatry. 2002 Jul;17(4):238-9. No abstract available.

PMID:
12231274
26.

Angiotensin converting enzyme gene insertion/deletion polymorphism: case-control association studies in schizophrenia, major affective disorder, and tardive dyskinesia and a family-based association study in schizophrenia.

Segman RH, Shapira Y, Modai I, Hamdan A, Zislin J, Heresco-Levy U, Kanyas K, Hirschmann S, Karni O, Finkel B, Schlafman M, Lerner A, Shapira B, Macciardi F, Lerer B.

Am J Med Genet. 2002 Apr 8;114(3):310-4.

PMID:
11920854
27.

Olanzapine and Huntington's disease.

Bogelman G, Hirschmann S, Modai I.

J Clin Psychopharmacol. 2001 Apr;21(2):245-6. No abstract available.

PMID:
11270928
28.

Pindolol augmentation in aggressive schizophrenic patients: a double-blind crossover randomized study.

Caspi N, Modai I, Barak P, Waisbourd A, Zbarsky H, Hirschmann S, Ritsner M.

Int Clin Psychopharmacol. 2001 Mar;16(2):111-5.

PMID:
11236069
29.

Touch feel illusion in schizophrenic patients.

Peled A, Ritsner M, Hirschmann S, Geva AB, Modai I.

Biol Psychiatry. 2000 Dec 1;48(11):1105-8.

PMID:
11094144
30.

Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial.

Hirschmann S, Dannon PN, Iancu I, Dolberg OT, Zohar J, Grunhaus L.

J Clin Psychopharmacol. 2000 Oct;20(5):556-9.

PMID:
11001241
31.

Sudden death in patients receiving clozapine treatment: a preliminary investigation.

Modai I, Hirschmann S, Rava A, Kurs R, Barak P, Lichtenberg P, Ritsner M.

J Clin Psychopharmacol. 2000 Jun;20(3):325-7.

PMID:
10831019
32.

Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial.

Dannon PN, Sasson Y, Hirschmann S, Iancu I, Grunhaus LJ, Zohar J.

Eur Neuropsychopharmacol. 2000 May;10(3):165-9.

PMID:
10793318
33.

Aminophylline increases seizure length during electroconvulsive therapy.

Stern L, Dannon PN, Hirschmann S, Schriber S, Amytal D, Dolberg OT, Grunhaus L.

J ECT. 1999 Dec;15(4):252-7.

PMID:
10614031
34.

Chronic treatment with repetitive transcranial magnetic stimulation inhibits seizure induction by electroconvulsive shock in rats.

Fleischmann A, Hirschmann S, Dolberg OT, Dannon PN, Grunhaus L.

Biol Psychiatry. 1999 Mar 15;45(6):759-63.

PMID:
10188006
35.

Labetalol does not lengthen asystole during electroconvulsive therapy.

Dannon PN, Iancu I, Hirschmann S, Ross P, Dolberg OT, Grunhaus L.

J ECT. 1998 Dec;14(4):245-50.

PMID:
9871845
36.

Melatonin for the treatment of sleep disturbances in major depressive disorder.

Dolberg OT, Hirschmann S, Grunhaus L.

Am J Psychiatry. 1998 Aug;155(8):1119-21.

PMID:
9699707
37.

Clozapine for the treatment of agitated-depressed patients with cognitive impairment: a report of three cases.

Nacasch N, Dolberg OT, Hirschmann S, Dannon P, Grunhaus LJ.

Clin Neuropharmacol. 1998 Mar-Apr;21(2):132-4.

PMID:
9579302
38.

Delirium in elderly patients treated with risperidone: a report of three cases.

Ravona-Springer R, Dolberg OT, Hirschmann S, Grunhaus L.

J Clin Psychopharmacol. 1998 Apr;18(2):171-2. No abstract available.

PMID:
9555603
39.

The treatment of comorbid premature ejaculation and panic disorder with fluoxetine.

Kindler S, Dolberg OT, Cohen H, Hirschmann S, Kotler M.

Clin Neuropharmacol. 1997 Oct;20(5):466-71.

PMID:
9331524
40.

Sleep-onset rapid eye movement after electroconvulsive therapy is more frequent in patients who respond less well to electroconvulsive therapy.

Grunhaus L, Shipley JE, Eiser A, Pande AC, Tandon R, Krahn DD, Demitrack MA, Remen A, Hirschmann S, Greden JF.

Biol Psychiatry. 1997 Aug 1;42(3):191-200.

PMID:
9232211
41.

ECT in patients with major depressive disorder and low cardiac output.

Stern L, Hirschmann S, Grunhaus L.

Convuls Ther. 1997 Jun;13(2):68-73.

PMID:
9253526
42.

Pathologic changes in gonadotropin releasing hormone agonist analogue treated uterine leiomyomata.

Deligdisch L, Hirschmann S, Altchek A.

Fertil Steril. 1997 May;67(5):837-41.

PMID:
9130887
43.

[Anorexia nervosa beginning after the menopause].

Hirschmann S, Apter A, Weizmann A, Radwan M.

Harefuah. 1996 Jul;131(1-2):10-2, 71. Hebrew.

PMID:
8854468
44.

Pharmacokinetics of cefaclor in patients with stable renal impairment, and patients undergoing haemodialysis.

Gartenberg G, Meyers BR, Hirschmann SZ, Srulevitch E.

J Antimicrob Chemother. 1979 Jul;5(4):465-70. No abstract available.

PMID:
489494

Supplemental Content

Loading ...
Support Center